Champions Oncology, Inc. (CSBR)

Champions Oncology Income Statement

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Revenue	56.88	56.94	50.16	53.87	49.11	41.04
Revenue Growth (YoY)	10.11%	13.54%	-6.90%	9.70%	19.66%	27.76%
Cost of Revenue	29.31	28.39	29.4	29.53	23.63	21.45
Gross Profit	27.57	28.56	20.75	24.34	25.48	19.59
Selling, General & Admin	17.1	16.88	18.13	17.24	15.5	12.03
Research & Development	7.45	6.83	9.54	11.55	9.37	7.2
Other Operating Expenses	-	0.29	0.44	0.81	-	-
Total Operating Expenses	24.56	24	28.11	29.59	24.87	19.23
Operating Income	3.01	4.55	-7.36	-5.26	0.61	0.37
Total Non-Operating Income (Expense)	-	0.07	0.05	-0.01	-0.02	0.07
Pretax Income	3.01	4.63	-7.31	-5.27	0.58	0.44
Provision for Income Taxes	-	-	-	0.07	0.04	0.08
Net Income	2.92	4.7	-7.28	-5.34	0.55	0.36
Net Income to Common	2.92	4.7	-7.28	-5.34	0.55	0.36
Net Income Growth	-	-	-	-	51.38%	-
Shares Outstanding (Basic)	3,457	14	14	14	13	13
Shares Outstanding (Diluted)	3,458	14	14	14	14	15
Shares Change (YoY)	-1.79%	5.31%	0.04%	-4.37%	-2.84%	23.05%
EPS (Basic)	0.21	0.34	-0.54	-0.39	0.04	0.03
EPS (Diluted)	0.20	0.33	-0.54	-0.39	0.04	0.02
EPS Growth	-	-	-	-	100.00%	-
Free Cash Flow	7.24	7	-6.97	1.1	4.11	-4.96
Free Cash Flow Growth	3.47%	-	-	-73.26%	-	-
Free Cash Flow Per Share	0.00	0.49	-0.51	0.08	0.29	-0.34
Gross Margin	48.47%	50.15%	41.38%	45.18%	51.88%	47.74%
Operating Margin	5.29%	8.00%	-14.67%	-9.76%	1.24%	0.89%
Profit Margin	5.29%	8.12%	-14.57%	-9.90%	1.12%	0.88%
FCF Margin	12.73%	12.29%	-13.90%	2.04%	8.38%	-12.09%
EBITDA	4.56	6.19	-5.49	-3.01	2.23	1.55
EBITDA Margin	8.02%	10.88%	-10.94%	-5.59%	4.55%	3.78%
EBIT	3.01	4.55	-7.36	-5.26	0.61	0.37
EBIT Margin	5.29%	8.00%	-14.67%	-9.76%	1.24%	0.89%
Effective Tax Rate	0.00%	0.00%	0.00%	-1.29%	6.00%	17.16%

Updated Jul 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q